Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency.
Galeotti, Caroline
Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency. [electronic resource] - Rheumatology (Oxford, England) Oct 2012 - 1855-9 p. digital
Publication Type: Journal Article
1462-0332
10.1093/rheumatology/kes097 doi
Adolescent
Adult
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Child
Child, Preschool
Female
Humans
Immunologic Factors--therapeutic use
Interleukin 1 Receptor Antagonist Protein--therapeutic use
Interleukin-1beta--antagonists & inhibitors
Male
Mevalonate Kinase Deficiency--drug therapy
Treatment Outcome
Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency. [electronic resource] - Rheumatology (Oxford, England) Oct 2012 - 1855-9 p. digital
Publication Type: Journal Article
1462-0332
10.1093/rheumatology/kes097 doi
Adolescent
Adult
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Child
Child, Preschool
Female
Humans
Immunologic Factors--therapeutic use
Interleukin 1 Receptor Antagonist Protein--therapeutic use
Interleukin-1beta--antagonists & inhibitors
Male
Mevalonate Kinase Deficiency--drug therapy
Treatment Outcome